January 08, 2025--(BUSINESS WIRE)--MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, today announced the in ...
Rounding out the C-suite as chief scientific officer is Christoph Lengauer, another ex-Third Rock partner and co-founder of MOMA Therapeutics, Celsius Therapeutics, and Thrive Earlier Detection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback